Josephson Neil's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 11, 2022
- Accession no.
- 0000899243-22-001679
- Filed
- Jan 11, 2022
- Trade date
- Jan 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $71.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Josephson NeilCIK 0001864141 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Common Shares | PPurchaseAcquired | +1,400 | $14.27 | +$19,978 | 3,519 | Direct | |
| Jan 7, 2022 | Common Shares | PPurchaseAcquired | +3,600 | $14.28 | +$51,408 | 7,119 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.